Valid and up to date QQ0-400 exam study guide with Latest Topics

killexams.com works with a huge number of up-and-comers to finish the QQ0-400 test and get their affirmation. We have a huge number of effective tributes. Our QQ0-400 exam dumps is solid, modest, exceptional, and legitimate to defeat the issues of QQ0-400 test. Our QQ0-400 test study guide are most recently refreshed on ordinary premise and Cheatsheet are reconsidered intermittently as indicated by the actual test.

Exam Code: QQ0-400 Practice test 2022 by Killexams.com team
QQ0-400 HDI Qualified Customer Support Specialist

This certification verifies that customer service professionals are knowledgeable in the skills and techniques required to provide exceptional customer service and support in both support center and call center environments. It ensures they understand how to assess customer needs while exceeding their expectations.

Frontline customer service representatives interact with your customers every day. Do they have the skills to create first-rate customer experiences? This skills-building and certification course introduces the skills and techniques required to provide outstanding customer service and support.

HDI Customer Service Representative (HDI-CSR) training focuses on call handling best practices, communication and listening techniques, documentation, problem-solving, and troubleshooting skills, conflict negotiation, and responses to difficult customer behaviors.

- How to assess customer business needs and exceed customer expectations - Critical thinking skills to resolve incidents quickly and consistently - Active listening skills and effective communication strategies - How to identify and defuse challenging customer behavior - An awareness of the core processes and best practices used in service and support
Unit 1: Your Role in Service and Support
The Service & Support Center
The Role of CSR
The Value of a CSR
Understanding the Business
Unit 2: Communication Essentials
Communication Essentials
Active Listening
Voice Components
Effective Word Choices
Written Communication
Effective Cross-Cultural Communication
Unit 3: Troubleshooting & Incident Management
Troubleshooting and Problem-solving
The Incident Management Process
Unit 4: Customer Management Skills
Challenging Customer Behaviors
Emotional Intelligence
Expressing Empathy
Managing Customer Behaviors
Stress Management

The certification test is included with training purchased directly from HDI. The test must be completed within 6 weeks of purchase.The certification test is based on the Certification Standard and is delivered online through the HDI Learning Center.

Each test consists of 30 multiple choice questions and must be completed in 35 minutes. A minimum score of 80 percent is required to pass a certification exam, unless otherwise published. Individuals who achieve the passing score will receive a certificate from HDI acknowledging their accomplishment and a credentialing logo that may be added to signature blocks and business cards.

Our courses are developed from the certification standards and are designed to assist a student in preparing for an HDI certification exam. They reinforce the core concepts of the certification standards and provide skills-building opportunities for the attendees

Exam Weighting
The certification test is randomly generated from a pool of pre-authorized test questions. As a result, each certification test is different. The questions have been classified by the categories of the HDI Standard. The certification test is designed to test the candidates knowledge in each category. The number of questions presented from each category is based on the certification weighting. When the time available to study prior to taking a certification test is limited, consider the certification weighting and review the categories with the highest allocations.

The following table represents the weighting for each of the standards categories within the certification exam. This information is provided to help you focus as you prepare for the exam.

Category Weighting %
Leadership 10 %
Policy and Strategy 10 %
People Management 10 %
Resources 10 %
Process and Procedures 55 %
Performance Results 5 %

HDI Qualified Customer Support Specialist
HDI Specialist study help
Killexams : HDI Specialist study help - BingNews https://killexams.com/pass4sure/exam-detail/QQ0-400 Search results Killexams : HDI Specialist study help - BingNews https://killexams.com/pass4sure/exam-detail/QQ0-400 https://killexams.com/exam_list/HDI Killexams : Schools need more specialist help for primary-age children with additional needs

Primary schools need more specialist help to deal with vulnerable children with additional needs as some are being left out of mainstream education for too long, Ofsted says.

The last five years has seen the number of primary school-age children who have been referred to alternative provision (AP) surge by a quarter to 7,000.

These units are used when a school cannot manage the child’s physical or verbally violent behaviour, and the negative effects it may have on other pupils and staff.

Ofsted chief inspector Amanda Spielman said: “It seems shocking that primary age children as young as five could be taken out of school for violent behaviour”, but APs can be a “positive choice” for these children.

She warned: “Limited access to external services and lengthy waiting times for a special school place, mean some vulnerable children languish for years in APs that cannot provide the specialist support they need.

“And the consequences for these children may last well into their adult lives.”

She was speaking after Ofsted carried out research involving interviews with parents plus school and local authority staff to find out why the children were being referred to AP’s in the first place, the challenges faced in trying to support the pupils and how these units may help them.

Most primary-age pupils only stayed in AP for a few weeks or months, and usually attended part time, according to Ofsted which found that some children with additional needs stayed in AP for years while they waited for a special school place.

This meant that AP staff may have been unable to fully meet their needs in the meantime and this lack of appropriate teaching and specialist support could have long-term consequences for these vulnerable children, Ofsted said.

Primary school staff said the strain on specialist services nationally, which had only got worse because of the pandemic, had made it more difficult to support pupils with special educational needs.

It was feared that limited access to professional help, such as speech and language therapists or educational psychology services, may have led to more AP referrals and possibly more permanent exclusions.

A lack of training, funding or facilities and a breakdown in the relationship between parents and school saw children referred to AP, Ofsted heard.

An AP referral was sometimes used in these cases as a “circuit breaker” to try and help repair these relationships while an effort was still being made to support the child. The AP effectively became a mediator between the school and parents.

School staff believed a pupils’ violent behaviour often stemmed from difficult home lives or undiagnosed special educational needs and disability (Send). A large majority of children in the study had social, emotional and health needs, Ofsted found.

Many staff expected the pupil would return to mainstream education while work would be carried out between the child, school and AP to find a better setting for them to attend in the future, such as a special school.

AP’s were seen by schools as an important way to spot the child’s needs early and to try and prevent their behaviour from escalating. In turn, AP staff said that funding matters had dealt a blow to the amount of outreach work they could do.

Ofsted found that some APs had specialist teams on site, so that pupils’ needs could be understood and addressed quickly.

The families of these children – which may include parents with their own emotional, cognitive or learning needs – might also be able to get help from the APs.

All parents involved in the research told Ofsted their child’s behaviour and academic work had improved since joining an AP, but some were unsure whether that would lead to a substantial “change” that would leave them as happy infants once they had left the unit.

Mon, 07 Nov 2022 10:13:00 -0600 en-US text/html https://www.aol.com/schools-more-specialist-help-primary-000100986.html
Killexams : Car insurance: HDI customers in Poland

This report offers the reader a comprehensive overview of HDI customers in Poland: who they are; what they like; what they think; and how to reach them. It provides insights on their demographics, lifestyle, opinions, and marketing touchpoints. Additionally, the report allows the reader to benchmark HDI customers in Poland (''brand users'') against Polish car insurance holders in general (''category users''), and the overall Polish onliner, labelled as ''all respondents'' in the charts. The report is updated quarterly and is based on data from the Statista Global Consumer Survey, an international survey that covers more than 14,500 brands across 56 countries.

Wed, 27 Jul 2022 08:30:00 -0500 en text/html https://www.statista.com/study/95482/car-insurance-hdi-in-poland-brand-report/
Killexams : QOL Up With Pembrolizumab Versus Ipilimumab, HDI in Resected Melanoma

MONDAY, Nov. 28, 2022 (HealthDay News) -- For patients with high-risk resected melanoma, adjuvant pembrolizumab improves quality of life (QOL) compared with standard of care with ipilimumab or high-dose interferon α 2b (HDI), according to a study published online Nov. 23 in JAMA Oncology.

Joseph M. Unger, Ph.D., from the Fred Hutchinson Cancer Center in Seattle, and colleagues compared QOL in patients with resected melanoma at high risk for relapse who were treated with adjuvant pembrolizumab or standard of care. A total of 832 patients from the S1404 phase 3 randomized clinical trial were included and were evaluable for the primary QOL end point at cycle 3.

The researchers found that the adjusted Functional Assessment of Cancer Therapy (FACT) Biological Response Modifiers (FACT-BRM) trial outcome index (TOI) score at cycle 3 was 9.6 points higher for pembrolizumab versus ipilimumab/HDI, which exceeded the prespecified clinically meaningful difference. Differences by arm exceeded 5 points in favor of pembrolizumab in linear-mixed models through cycle 7. FACT-BRM TOI scores favored the pembrolizumab arm compared with the subset of patients receiving ipilimumab or HDI (differences, 6.0 and 17.0 points, respectively) in post-hoc analyses.

"Physicians should be encouraged to incorporate and discuss treatment-related QOL issues with patients when making shared decisions regarding the risks and benefits of adjuvant therapy in resected melanoma," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Merck, which manufactures pembrolizumab and partially funded the study.

Mon, 28 Nov 2022 03:55:00 -0600 en text/html https://roanoke.com/lifestyles/health-med-fit/qol-up-with-pembrolizumab-versus-ipilimumab-hdi-in-resected-melanoma/article_e1fa28d4-cf62-5d96-bf8b-1979b5018538.html
Killexams : HDI Global Specialty selects Sapiens for complete P&C core transformation

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Tue, 22 Nov 2022 23:28:00 -0600 en text/html https://seekingalpha.com/news/3911113-hdi-global-specialty-selects-sapiens-for-complete-pc-core-transformation
Killexams : HDI Announces Third Quarter 2022 Results

Quarterly Dividend Increase of 8%

LANGLEY, BC, Nov. 8, 2022 /CNW/ - Hardwoods Distribution Inc. ("HDI" or the "Company") today announced financial results for the three and nine months ended September 30, 2022 and an 8% increase to the quarterly dividend. HDI is one of North America's largest suppliers of specialty building products to fabricators, home centers and professionals dealers servicing the repair and remodel, residential, and commercial construction end-markets. The Company currently operates a network of 86 facilities in the United States and Canada. All amounts are shown in United States dollars ("U.S. $" or "$"), unless otherwise noted.

Third Quarter Highlights

  • Third quarter sales grew 39.9% to $659.7 million, a year-over-year increase of $188.0 million. Achieved organic sales growth of 10.4% and acquisition-based sales growth of 29.9%.

  • Gross profit climbed 19.6%, or $22.8 million, to $139.0 million, with gross profit margin percentage of 21.1%, as compared to 24.6% in the same period last year.

  • Profit per share was $1.28; adjusted profit per share was $1.32 per share

  • Adjusted EBITDA climbed 3.4% to $66.0 million, from $63.8 million during the same period in 2021.

  • Cash flow from operating activities, before changes in working capital, was $1.84 per share.

  • In Canadian dollars, sales for the third quarter were C$856.7 million, adjusted profit per share was C$1.71, and Adjusted EBITDA was C$85.7 million.

  • The board of directors today approved an 8% increase to the quarterly dividend to C$0.13 per share, from C$0.12 per share previously, which equates to C$0.52 per share on an annual basis. The increase is effective with the quarterly dividend payable on January 27, 2023 to shareholders of record as at January 16, 2023.

"We achieved another quarter of excellent financial and operating performance as our growth strategy, proven business model and disciplined operating management combined to deliver very strong third quarter results," said Rob Brown, HDI's President and CEO. "Market conditions remained supportive of our business, with increased product prices resulting in strong organic sales growth of over 10% as compared to the same quarter last year. Combined with acquisition-based growth, our total sales grew nearly 40% year-over-year."

"Our results reflect the positive impact of our new Mid-Am and Novo operations, acquired in Q3 2021 and Q1 2022, respectively. These businesses have brought us important scale, access to new geographies, and a strong presence in the U.S. Pro Dealer and home center channels, and combined, are expected to deliver over $1 billion in pro forma sales in 2022."

"Importantly, our performance has enabled us to increase our returns to investors. In the first nine months of 2022, we returned almost $25 million to shareholders through a combination of dividends and share repurchases, up from $5.0 million in the same period last year. With today's announcement of an 8% increase to our quarterly dividend, we are providing further returns to our shareholders going forward."

"Going forward, we will continue to closely monitor economic conditions and the impacts that price inflation, rising interest rates, and other factors can have on our business. We benefit from a highly experienced team with a long track record of successfully managing our operations and controlling costs through changing markets. We believe our business has the resilience to manage through these cycles, and we anticipate a multi-year runway for growth and value creation as we benefit from our leading market position and the long-term positive fundamentals underpinning the North American building products market," said Mr. Brown.

Outlook

In the nearer term we anticipate that rising inflation and accurate interest rate hikes will have a negative impact on economic activity, and this may result in a moderation of demand for our products. As we have demonstrated in previous cycles, we will take all necessary actions required to effectively manage our business and cash flows. We maintain a strong balance sheet which provides financial stability through periods of changing market conditions. Our business model also converts a high proportion of EBITDA to operating cash flow before changes in working capital, and during periods of reduced activity our investment in working capital has historically decreased, resulting in an additional source of cash.

Over the long term we expect demand for our products to remain robust, supported by strong fundamentals in our end markets. We continue to see a multi-year runway for growth in the repair and remodel, residential, and commercial end-markets that we participate in.

Outlook for our end-markets

The repair and remodel market (~40% of sales) is expected to remain strong, albeit with a tempering of the higher-than-normal growth rates experienced in the past year. The Joint Center for Housing Studies of Harvard University anticipates a growth rate of 6.5% for the U.S. repair and remodel market by the third quarter of 2023. Overall, the market remains well supported by record levels of home equity in the U.S. and a median home age of over 40 years. Disaster repairs and mitigation projects following Hurricane Ian are also expected to support the home remodeling market in the coming year.

In the residential construction market (~40% of sales), new building starts have moderated as affordability headwinds weigh on consumers, but remain at historically healthy levels. Given that housing completions have not kept pace with starts over the past quarters, we also continue to see an elongated demand curve for our products, which are typically installed during the finishing stages of home construction. Over the longer term, leading indicators for the residential construction market remain highly favorable. Housing starts have meaningfully lagged population growth this past decade, and it is estimated that the U.S. has a housing supply deficit of over 3.5 million units. This supply deficit, combined with positive demographic factors, is expected to underpin long-term demand for new housing.

The demand outlook for U.S. commercial markets (~15% of sales) is mixed, with some sectors showing strength and others recovering at a slower pace. Commercial market participation is highly diverse for HDI and includes construction activity in healthcare, education, public buildings, hospitality, office, retail facilities and recreational vehicles. We expect certain of these commercial end markets will perform better than others, with the broad nature of our participation reducing the impact of dynamics in any one geography or end market.

Q3 2022 Investor Call

HDI will hold an investor call on Wednesday November 9, 2022 at 8:00 am Pacific (11:00 am Eastern). Participants should dial 1-888-254-3590 or (647) 484-0475 (GTA) at least five minutes before the call begins. A replay will be available through November 16, 2022 by calling toll free 1-888-390-0541 or (416) 764-8677 (GTA), followed by passcode 852499.

Summary of Results

Three months

Three months

Nine months

Nine months

ended
September 30

ended
September 30

ended
September 30

ended
September 30

2022

2021

2022

2021

Total sales

$           659,685

$          471,673

$        2,004,834

$         1,100,846

Sales in the US

610,360

426,738

1,847,481

970,393

Sales in Canada (C$)

64,496

56,660

201,853

163,535

Gross profit

138,964

116,190

440,575

250,020

Gross profit %

21.1 %

24.6 %

22.0 %

22.7 %

Operating expenses

(90,902)

(67,303)

(268,549)

(148,160)

Profit from operating activities

$             48,062

$            48,887

$          172,026

$           101,860

Add: Depreciation and amortization

16,830

11,748

48,523

24,063

Earnings before interest, taxes, depreciation and

amortization ("EBITDA")

$             64,892

$            60,635

$          220,549

$           125,923

EBITDA as a % of revenue

9.8 %

12.9 %

11.0 %

11.4 %

Add (deduct):

Depreciation and amortization

(16,830)

(11,748)

(48,523)

(24,063)

Net finance income (expense)

(8,926)

(3,803)

(20,097)

(6,664)

Income tax expense

(9,260)

(11,387)

(36,650)

(24,196)

Profit for the period

$            29,876

$           33,696

$         115,279

$             71,000

Basic profit per share

$                1.28

$               1.58

$               4.89

$3.34

Diluted profit per share

$                1.27

$               1.56

$               4.85

$3.29

Average Canadian dollar exchange rate for one US dollar

$                0.77

$               0.79

$               0.78

0.799

Analysis of Specific Items Affecting Comparability (in thousands of Canadian dollars)

Three months

Three months

Nine months

Nine months

ended
September 30

ended
September 30

ended
September 30

ended
September 30

2022

2021

2022

2021

Earnings before interest, taxes, depreciation and

amortization ("EBITDA"), per table above

$             64,892

$            60,635

$          220,549

$           125,923

Non-cash LTIP expense

1,075

1,288

2,927

3,576

Transaction expenses

1,903

892

4,071

Adjusted EBITDA

$             65,967

$            63,826

$          224,368

$           133,570

Adjusted EBITDA as a % of revenue

10.0 %

13.5 %

11.2 %

12.1 %

Profit for the period, as reported

$             29,876

$            33,696

$          115,279

$             71,000

Adjustments, net of tax

957

2,579

3,256

6,310

Adjusted profit for the period

$             30,833

$            36,275

$          118,535

$             77,310

Basic profit per share, as reported

$                 1.28

$                1.58

$                4.89

$                 3.34

Net impact of above items per share

0.04

0.12

0.14

0.30

Adjusted basic profit per share

$                 1.32

$                1.70

$                5.03

$                 3.64

Diluted profit per share, as reported

$                 1.27

$                1.56

$                4.85

$                 3.29

Net impact of above items per share

0.04

0.12

0.14

0.29

Adjusted diluted profit per share

$                 1.31

$                1.68

$                4.99

$                 3.58


Results from Operations - Three Months Ended September 30, 2022

For the three months ended September 30, 2022, consolidated sales grew to  $659.7 million, an increase of $188.0 million, or 39.9%, from $471.7 million in the same period in 2021. Organic sales growth accounted for $48.9 million of this gain, representing a 10.4% increase in consolidated sales.  Acquired businesses (the "Acquired Businesses") contributed an additional $140.9 million of the sales growth, and included Novo's July 2022 revenue of $58.8 million and Mid-Am's Q3 2022 revenue of $82.0 million. Combined, additional revenue from Acquired Businesses represented a 29.9% increase in total sales. These gains were partially offset by $1.8 million of unfavorable foreign exchange impact.

Third quarter sales from our U.S. operations grew to $610.4 million, an increase of $183.6 million, or 43.0%, from $426.7 million in the same period in 2021. Organic sales growth accounted for $42.7 million of this improvement, representing a 10.0%  increase in U.S. sales. The strong organic growth was primarily supported by increased product prices, partially offset by a modest decrease in volumes. Incremental revenue from Acquired Businesses contributed an additional $140.9 million to third quarter U.S. sales growth, representing a 33% increase in U.S. sales.

In Canada, third quarter sales increased by C$7.8 million, or 13.8%, compared to the same period in 2021. The Canadian sales growth was entirely organic and reflects higher product prices year-over-year, partially offset by a modest decrease in volumes.

Gross profit for the third quarter grew 19.6% to $139.0 million, from $116.2 million in the same quarter last year. This $22.8 million improvement reflects the significant sales growth, partially offset by a lower gross margin percentage.  At 21.1%, our gross margin percentage did not match the unusually high 24.6% achieved in Q3 2021 when favorable market dynamics, including strong demand and tight supply, resulted in a rapid increase in product prices as compared to the cost of inventory.

For the three months ended September 30, 2022, operating expenses increased by $23.6 million to $90.9 million, from $67.3 million in Q3 2021. As a percentage of sales, operating expenses were lower at 13.8%, as compared to 14.3% in the same period last year.

The $23.6 million increase in operating expenses includes $15.8 million related to incremental operating expenses from our Acquired Businesses, $6.4 million to support organic growth, and $3.3 million of amortization on intangible assets acquired in connection with the Novo and Mid-Am acquisitions. These increases were partially offset by $1.9 million of Novo-related transaction costs incurred in Q3 2021, which did not repeat in 2022.

For the three months ended September 30, 2022, depreciation and amortization increased to $16.8 million, from $11.7 million in Q3 2021. This $5.1 million increase primarily relates to the acquisition and operations of the Novo and Mid-Am businesses and is comprised of $3.3 million of amortization on acquired intangible assets and $1.8 million from depreciation related to operations.

For the three months ended September 30, 2022, net finance expense increased to $8.9 million, from $3.8 million last year. This increase was primarily driven by interest costs on the additional bank indebtedness used to finance the acquisitions of Novo and Mid-Am, as well as higher interest rates.

For the three months ended September 30, 2022, income tax expense decreased to $9.3 million, from $11.4 million last year, primarily reflecting lower taxable income.

Third quarter Adjusted EBITDA climbed 3.4% to $66.0 million, from $63.8 million during the same period in 2021. The $2.2 million improvement was driven primarily by the $22.8 million increase in gross profit, partially offset by the $20.6 million increase in operating expenses (before changes in depreciation and amortization, non-cash LTIP expense, and transaction expenses).

Profit for the third quarter decreased by 11.3% to $29.9 million, from $33.7 million in Q3 2021. The $3.8 million change primarily reflects a $5.1 million increase in depreciation and amortization, and the $5.0 million increase in net finance expense, partially offset by the $4.3 million increase in EBITDA and $2.1 million lower income tax expense.

For the three months ended September 30, 2022, we generated basic profit per share of $1.28, as compared to $1.58 in Q3 2021, a decrease of 19.0%. Adjusted profit was $30.8 million, as compared to  $36.3 million in Q3 2021, a decrease of 15.0% and  Adjusted diluted profit per share was $1.31, as compared to $1.68, a decrease of 22.0%.

Results from Operations - Nine Months Ended September 30, 2022

For the nine months ended September 30, 2022, consolidated sales climbed 82.1% to $2.0 billion, an increase of $904.0 million from $1.1 billion in the same period in 2021. Organic sales growth accounted for $241.9 million of this gain, representing a 22.0% increase in consolidated sales. Acquisition-based revenue growth, including Novo's January to July 2022 revenue of $453.5 million, and Mid-Am's year-to-date revenue of $219.0 million, increased  consolidated revenue by a combined 61.1% year-over-year. These gains were partially offset by the first quarter 2021 divestiture of our HMI business, which resulted in $6.4 million of sales not recurring in the current period. Foreign exchange fluctuations in the Canadian dollar also had an unfavorable $4.0 million impact on sales results.

First nine months sales from our U.S. operations grew 90.4% to $1.8 billion, a year-over-year increase of $877.1 million, from $970.4 million in the same period last year. Organic sales growth accounted for $204.6 million of this improvement, representing a 21.1% year-over-year increase in U.S. sales. The strong organic growth was primarily supported by robust market demand, particularly during the first half of the year, which in turn contributed to improved product prices. The Novo and Mid-Am operations contributed an additional $672.5 million to year-to-date U.S. sales growth, representing a 69.3% increase in U.S. sales.

In Canada, sales for the first nine months increased by C$38.3 million, or 23.4%, compared to the same period in 2021. The Canadian sales growth was entirely organic and reflects the strong market demand particularly in the first half of the year, which resulted in improved market prices for our products year-over-year.

Gross profit for the first nine months grew 76.2% to $440.6 million, from $250.0 million in the same period last year. This $190.6 million improvement reflects our significant organic and acquisition-based sales growth. At 22.0%, our gross profit margin was slightly lower than the 22.7% we achieved in the same period last year. The gross margin percentage in 2021 was temporarily elevated due to favorable market dynamics, including strong demand and tight supply.

For the nine months ended September 30, 2022, operating expenses were $268.5 million as compared to $148.2 million in the same period last year, an increase of $120.4 million. As a percentage of sales, operating expenses were well controlled at 13.4%, similar to 13.5% in the first nine months of last year.

The $120.4 million increase in operating expenses includes $90.3 million related to operation of our Acquired Businesses, $21.0 million to support organic growth, and $12.3 million of amortization on intangible assets acquired in connection with the Novo and Mid-Am acquisitions. These increases were partially offset by $3.2 million of Novo-related transaction costs incurred in the first nine months of 2021, which did not repeat in the 2022 period.

For the nine months ended September 30, 2022, depreciation and amortization increased by $24.5 million to $48.5 million, from $24.1 million in the prior-year period. This increase mainly relates to the acquisition and operations of the Novo and Mid-Am businesses and is primarily comprised of $12.3 million of amortization on acquired intangible assets, and $12.1 million from depreciation related to operations.

For the nine months ended September 30, 2022, net finance expense increased to $20.1 million, from $6.7 million last year. The increase was primarily driven by interest on issuance of new bank indebtedness used to finance the acquisitions of Novo and Mid-Am, combined with higher interest rates.

For the nine months ended September 30, 2022, income tax expense increased to $36.7 million, from $24.2 million last year, primarily driven by a higher taxable income.

Year-to-date Adjusted EBITDA climbed 68.0% to $224.4 million, from $133.6 million in the same period of 2021. This $90.8 million improvement reflects the $190.6 million increase in gross profit, partially offset by the $99.8 million increase in operating expenses (before changes in depreciation and amortization, non-cash LTIP expense, and transaction expenses).

Profit for the first nine months grew 62.4% to $115.3 million, from $71.0 million in the first nine months of 2021. The $44.3 million profit improvement primarily reflects the $94.6 million increase in EBITDA, partially offset by a $24.5 million increase in depreciation and amortization, the $12.5 million increase in income tax expense, and the $13.4 million increase in net finance expense.

For the nine months ended September 30, 2022, basic profit per share climbed 46.4% to $4.89, from $3.34 in the same period last year. Adjusted profit increased 53.3% to $118.5 million, from $77.3 million in the first nine months of 2021 and Adjusted diluted profit per share grew 39.4% to $4.99, from $3.58 in the same period last year.

About HDI

HDI is one of North America's largest suppliers of specialty building products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end-markets. The Company currently operates a network in North America of 86 facilities in the United States and Canada. HDI's common shares are listed on the Toronto Stock Exchange under the symbol HDI.

Non-GAAP Measures - EBITDA

References to "EBITDA" are to earnings before interest, income taxes, depreciation and amortization, where interest is defined as net finance costs as per the consolidated statement of comprehensive income.  Furthermore, this press release references certain EBITDA Ratios, such as EBITDA margin (being EBITDA as a percentage of revenues).  In addition to profit, HDI considers EBITDA and EBITDA Ratios to be useful supplemental measures of the Company's ability to meet debt service and capital expenditure requirements, and interprets trends in EBITDA and EBITDA Ratios as an indicator of relative operating performance.

References to "Adjusted EBITDA" are EBITDA as defined above, before certain items related to business acquisition activities. "Adjusted EBITDA margin" is as defined above, before certain items related to business acquisition activities, mark-to-market adjustments, and revaluation of deferred tax assets. References to "Adjusted profit", "Adjusted basic profit per share", and "Adjusted diluted profit per share" are profit for the period, basic profit per share, and diluted profit per share, before certain items related to business acquisition activities, mark-to-market adjustments, and revaluation of deferred tax assets. The aforementioned adjusted measures are collectively referenced as "the Adjusted Measures". HDI considers the Adjusted Measures to be useful supplemental measures of the Company's profitability, its ability to meet debt service and capital expenditure requirements, and as an indicator of relative operating performance, before considering the impact of business acquisition activities.

EBITDA, EBITDA Ratios, and the Adjusted Measures (collectively "the Non-GAAP Measures") are not measures recognized by International Financial Reporting Standards ("IFRS") and do not have a standardized meaning prescribed by IFRS.  Investors are cautioned that the Non-GAAP Measures should not replace profit, earnings per share or cash flows (as determined in accordance with IFRS) as an indicator of our performance.  HDI's method of calculating the Non-GAAP Measures may differ from the methods used by other issuers. Therefore,  Non-GAAP Measures may not be comparable to similar measures presented by other issuers.

Forward-Looking Statements

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION

This news release includes forward-looking statements. These involve known and unknown risks, uncertainties and other factors that may cause genuine results, performance or achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are identified by the use of terms and phrases such as "anticipate", "believe", "estimate", "expect", "may", "plan", "will", and similar terms and phrases, including references to assumptions. Forward-looking information is included, but not limited to, information included under the headings "Second Quarter Highlights", "Outlook", "Results of Operations for the Three Months Ended September 30, 2022", and "Results of Operations for the Nine Months Ended September 30, 2022."

These forward-looking statements reflect current expectations of management regarding future events and operating performance as of the date of this news release. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause genuine results to differ materially from the results discussed in the forward-looking statements, including, but not limited to: it is difficult to reliably measure the potential impact of this uncertainty caused by the COVID-19 pandemic on our future financial results and the impacts to our Company are not determinable at the date of these financial statements, however they could be material and include impairments of receivables, inventory and reduction in available liquidity; given the uncertainty around the potential impact of COVID-19, this may impact our estimates disclosed in the consolidated financial statements given that there is significant judgment and estimation uncertainty; our results are dependent upon the general state of the economy and downturns in the economy (including inflation and rising interest rates), natural disasters, disease outbreaks, terrorist activities, or threats or acts of armed conflict (including the conflict between Russia and Ukraine), could have a negative impact on our business, financial condition, and results of operations; decreases in the supply of, demand for, or market values of our products could harm our business; our products may be subject to negative trade outcomes; we may not be able to sustain our level of sales or EBITDA margins; competition in our markets may lead to reduced revenues and profitability; we may become subject to more stringent regulations; we are dependent upon our management information systems; our insurance may be insufficient to cover losses that may occur as a result of our operations; we are dependent upon the financial condition and results of operations of our business; our credit facilities affect our liquidity, contain restrictions on our ability to borrow funds, and impose restrictions on distributions that can be made by our operating limited partnerships; and, other risks described in our Annual Information Form our Information Circular and in the MD&A.

Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, management cannot assure investors that genuine results will be consistent with these forward-looking statements. The forward-looking statements reflect management's current beliefs and are based on information currently available.

All forward-looking information in this news release is qualified in its entirety by this cautionary statement and, except as may be required by law, HDI undertakes no obligation to revise or update any forward-looking information as a result of new information, future events or otherwise after the date hereof.

SOURCE Hardwoods Distribution Inc.

Cision

View original content: http://www.newswire.ca/en/releases/archive/November2022/08/c0391.html

Wed, 09 Nov 2022 03:31:00 -0600 en-US text/html https://finance.yahoo.com/news/hdi-announces-third-quarter-2022-012700798.html
QQ0-400 exam dump and training guide direct download
Training Exams List